» Articles » PMID: 26670048

Mesenchymal Cancer Cell-Stroma Crosstalk Promotes Niche Activation, Epithelial Reversion, and Metastatic Colonization

Overview
Journal Cell Rep
Publisher Cell Press
Date 2015 Dec 17
PMID 26670048
Citations 120
Authors
Affiliations
Soon will be listed here.
Abstract

During metastatic colonization, tumor cells must establish a favorable microenvironment or niche that will sustain their growth. However, both the temporal and molecular details of this process remain poorly understood. Here, we found that metastatic initiating cells (MICs) exhibit a high capacity for lung fibroblast activation as a result of Thrombospondin 2 (THBS2) expression. Importantly, inhibiting the mesenchymal phenotype of MICs by blocking the epithelial-to-mesenchymal transition (EMT)-associated kinase AXL reduces THBS2 secretion, niche-activating ability, and, consequently, metastatic competence. Subsequently, disseminated metastatic cells revert to an AXL-negative, more epithelial phenotype to proliferate and decrease the phosphorylation levels of TGF-β-dependent SMAD2-3 in favor of BMP/SMAD1-5 signaling. Remarkably, newly activated fibroblasts promote this transition. In summary, our data reveal a crosstalk between cancer cells and their microenvironment whereby the EMT status initially triggers and then is regulated by niche activation during metastatic colonization.

Citing Articles

AXL promotes lymphangiogenesis by amplifying VEGF-C-mediated AKT pathway.

Pirson S, Gautier-Isola M, Baudin L, Rouaud L, Vanwynsberghe A, Deroye J Cell Mol Life Sci. 2025; 82(1):95.

PMID: 40011241 PMC: 11865408. DOI: 10.1007/s00018-024-05542-3.


Unveiling the link between chronic inflammation and cancer.

Tripathi S, Sharma Y, Kumar D Metabol Open. 2025; 25:100347.

PMID: 39876904 PMC: 11772974. DOI: 10.1016/j.metop.2025.100347.


Despicable role of epithelial-mesenchymal transition in breast cancer metastasis: Exhibiting restorative regimens.

Famta P, Shah S, Dey B, Kumar K, Bagasariya D, Vambhurkar G Cancer Pathog Ther. 2025; 3(1):30-47.

PMID: 39872366 PMC: 11764040. DOI: 10.1016/j.cpt.2024.01.001.


The complexity of immune evasion mechanisms throughout the metastatic cascade.

Haynes N, Chadwick T, Parker B Nat Immunol. 2024; 25(10):1793-1808.

PMID: 39285252 DOI: 10.1038/s41590-024-01960-4.


Single-cell analysis of breast cancer metastasis reveals epithelial-mesenchymal plasticity signatures associated with poor outcomes.

Winkler J, Tan W, Diadhiou C, McGinnis C, Abbasi A, Hasnain S J Clin Invest. 2024; 134(17).

PMID: 39225101 PMC: 11364385. DOI: 10.1172/JCI164227.


References
1.
Liu J, Deng T, Lehal R, Kim J, Zacksenhaus E . Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors. Cancer Res. 2007; 67(18):8671-81. DOI: 10.1158/0008-5472.CAN-07-1486. View

2.
Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer. 2007; 7(6):415-28. DOI: 10.1038/nrc2131. View

3.
Chen J, Li Y, Yu T, McKay R, Burns D, Kernie S . A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012; 488(7412):522-6. PMC: 3427400. DOI: 10.1038/nature11287. View

4.
Oskarsson T, Acharyya S, Zhang X, Vanharanta S, Tavazoie S, Morris P . Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med. 2011; 17(7):867-74. PMC: 4020577. DOI: 10.1038/nm.2379. View

5.
Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall J, Harrington K . Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol. 2007; 9(12):1392-400. DOI: 10.1038/ncb1658. View